Neuro Rehab Times: Exploring the gap in traumatic brain injury and concussion treatment

Oxeia’s CEOI MIchael Wyand recently spoke with Neuro Rehab Times, about the lack of an effective treatment for post-concussion symptoms despite the significant medical advances es in many other areas

Read More

Previous
Previous

Neurotrauma Reports: Injection of Ghrelin (OXE-103) Improves Subacute Concussion Symptom Burden and Quality of Life

Next
Next

GEN: Light Within the Black Hole of Concussion Therapeutics